INM
NASDAQ · Pharmaceuticals
Inmed Pharmaceuticals Inc
$1.42
+0.04 (+2.90%)
Open$1.40
Previous Close$1.38
Day High$1.44
Day Low$1.39
52W High$2.50
52W Low$0.58
Volume—
Avg Volume73.0K
Market Cap7.64M
P/E Ratio—
EPS$-2.88
SectorPharmaceuticals
Analyst Ratings
Strong Sell
8 analysts
Price Target
+2,269.7% upside
Current
$1.42
$1.42
Target
$33.65
$33.65
$24.21
$33.65 avg
$46.15
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 28.43M | 17.18M | 790.8K |
| Net Income | -46,956,445 | -25,527,514 | 172.0K |
| Profit Margin | -165.1% | -156.9% | 21.8% |
| EBITDA | -44,492,057 | -25,531,533 | 218.3K |
| Free Cash Flow | — | — | 109.5K |
| Rev Growth | +65.6% | +65.6% | +11.4% |
| Debt/Equity | — | — | 0.10 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |